Insiders Pfizer, Inc.

Equities

Market Closed - Nyse Other stock markets 04:01:39 2024-06-10 pm EDT			After market 04:50:47 pm
28.07 ^USD	-1.78%		28.08	+0.02%

09:34pm	Pfizer to Pause Sizable Acquisitions as it Integrates Existing Investments, CEO Says	MT
05:20pm	Transcript : Pfizer Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 11:20 AM

Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief	May. 23	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	May. 10	MT
Pfizer: Citi analyst appointed Chief Strategy Officer	May. 06	CF
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer	May. 06	MT
Pfizer Names Andrew Baum Chief Strategy, Innovation Officer	May. 06	DJ
Pfizer Announces Executive Changes	May. 06	CI
Avacta picks Christina Coughlin to replace long-serving CEO	May. 01	AN
Repeat & Correct : Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Who are OpenAI's new board members?	Mar. 11	RE
Moderna CEO: 'Excited' About Future Following 4Q Revenue	Feb. 22	MT
Pfizer Ltd. Names CFO	Jan. 21	MT
Ex-Pfizer employee convicted of insider trading on COVID drug trial	Jan. 18	RE
Top Stories at Midday: Chicago PMI Shifts Back to Contraction; Alibaba Loses JD.com Antitrust Case; BuzzFeed President to Resign; Pfizer, Other Drugmakers Plan Price Increases; Boeing Says China 737 Max Jets Back in Service	Dec. 29	MT
InnoCare Elects CFO	Dec. 18	MT
Pfizer Inc. Announces Management Changes	Dec. 12	CI
Pfizer Says Seagen Deal to Close Thursday; Commercial Operations to Be Restructured	Dec. 12	MT
Pfizer CFO Retires	Dec. 01	MT
Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs	23-10-31	MT
Pfizer CEO Albert Bourla: Seagen will bring in $10 billion in revenues by 2030	23-10-31	MT

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs